Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. [electronic resource]
- Hypertension (Dallas, Tex. : 1979) Jan 2002
- 87-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4563
10.1161/hy1201.097292 doi
Animals Apoptosis--genetics Cardiomegaly--drug therapy Cyclic GMP--analogs & derivatives Cyclic GMP-Dependent Protein Kinase Type I Cyclic GMP-Dependent Protein Kinases--biosynthesis Down-Regulation Drug Synergism Gene Transfer Techniques Humans Myocardium--cytology Nitric Oxide--pharmacology Nitric Oxide Donors--pharmacology Rats Rats, Sprague-Dawley Receptors, Adrenergic, alpha-1--physiology S-Nitroso-N-Acetylpenicillamine--pharmacology Thionucleotides--pharmacology